NEUROONE MEDICAL TECHNOLOGIES Corp 10-Q

Item 5. Other Information None. 38 NeuroOne Medical Technologies Corporation Form 10-Q Item 6. Exhibits 3.1 Certificate of Incorporation of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.4 on the Registrant’s Current Report on Form 8 filed on June 29, 2017). 3.2 Certificate of Amendment to Amended and Restated Certificate of Incorporation of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.1 on the Registrant’s Current Report on Form 8-K filed on March 31, 2021). 3.3 Bylaws of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.5 on the Registrant’s Current Report on Form 8-K filed on June 29, 2017). 4.1 Warrant to Purchase Common Stock dated as of August 2, 2022 issued to Zimmer, Inc. 10.1 Amendment No. 2 to Exclusive Development and Distribution Agreement dated as of July 1, 2022 by and between the Company and Zimmer, Inc. 10.2 Amendment No. 3 to Exclusive Development and Distribution Agreement dated as of August 2, 2022 by and between the Company and Zimmer, Inc. 31.1 Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.2 Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 32.1* Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 32.2* Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 101.INS Inline XBRL Instance Document. 101.SCH Inline XBRL Taxonomy Extension Schema Document. 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document. 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document. 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document. 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document. 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). * Documents are furnished, not filed. 39 NeuroOne Medical Technologies Corporation Form 10-Q SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized. Dated: August 11, 2022 NeuroOne Medical Technologies Corporation By: /s/ David Rosa David Rosa Chief Executive Officer (Principal Executive Officer) By: /s/ Ronald McClurg Ronald McClurg Chief Financial Officer (Principal Financial Officer) 40